69 FR 172 pg. 54149 - Scientific Considerations Related to Developing Follow-On Protein Products; Correction
Type: NOTICEVolume: 69Number: 172Page: 54149
Docket number: [Docket No. 2004N-0355]
FR document: [FR Doc. 04-20289 Filed 9-1-04; 4:34 pm]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N-0355]
Scientific Considerations Related to Developing Follow-On Protein Products; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of public workshop; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of August 16, 2004 (69 FR 50386). The document announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products. The document was published with an inadvertent error. This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.
In FR Doc. 04-18627 appearing on page 50386 in the issue of August 16, 2004, the following correction is made: On page 50386, in the third column, under the heading ADDRESSES , in the second paragraph add a new second sentence to read: Submit electronic comments to http://www.fda.gov/dockets/ecomments .
Dated: August 31, 2004.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 04-20289 Filed 9-1-04; 4:34 pm]
BILLING CODE 4160-01-S